Skip to main content
Livermore
Livermore
ZHEN

Adaptimmune Therapeutics PLC

ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001621227

No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Adaptimmune Therapeutics PLC as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
79
0 vs. Q3 2023
Shares held
143.6M
−4.73M (−3.2%) vs. Q3 2023
Total value
$113.9M
−$1.83M (−1.6%) vs. Q3 2023
New holders
14
14 more added
Sold out
14
27 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 79 institutions
Q1 2021: 84 institutionsQ2 2021: 82 institutionsQ3 2021: 92 institutionsQ4 2021: 85 institutionsQ1 2022: 80 institutionsQ2 2022: 77 institutionsQ3 2022: 68 institutionsQ4 2022: 69 institutionsQ1 2023: 65 institutionsQ2 2023: 89 institutionsQ3 2023: 79 institutionsQ4 2023: 79 institutionsQ1 2024: 80 institutionsQ2 2024: 76 institutionsQ3 2024: 81 institutionsQ4 2024: 80 institutionsQ1 2025: 67 institutionsQ2 2025: 65 institutionsQ3 2025: 55 institutionsQ4 2025: 10 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ4 2023: $113.9M
Q1 2021: $623.8MQ2 2021: $475.7MQ3 2021: $577.3MQ4 2021: $425.9MQ1 2022: $229.2MQ2 2022: $195.1MQ3 2022: $122.4MQ4 2022: $166.3MQ1 2023: $126.4MQ2 2023: $133.9MQ3 2023: $115.7MQ4 2023: $113.9MQ1 2024: $256.1MQ2 2024: $150.0MQ3 2024: $144.1MQ4 2024: $67.0MQ1 2025: $22.9MQ2 2025: $27.7MQ3 2025: $5.47MQ4 2025: $79.7KQ1 2026: $72Q2 2026: $0
Institutions holding ADAPY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$72
Q4 202510$79.7K
Q3 202555$5.47M
Q2 202565$27.7M
Q1 202567$22.9M
Q4 202480$67.0M
Q3 202481$144.1M
Q2 202476$150.0M
Q1 202480$256.1M
Q4 202379$113.9M
Q3 202379$115.7M
Q2 202389$133.9M
Q1 202365$126.4M
Q4 202269$166.3M
Q3 202268$122.4M
Q2 202277$195.1M
Q1 202280$229.2M
Q4 202185$425.9M
Q3 202192$577.3M
Q2 202182$475.7M
Q1 202184$623.8M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q3 2023.

Institutions holding ADAPY in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada592$00.00%−18,433−96.9%Reduced
Simplex Trading, LLC300$00.00%+300New
Group One Trading, L.P.51$400.00%+51New
Investors Research Corp100$790.00%00.0%Unchanged
Advisory Services Network, LLC125$990.00%+125New
HighMark Wealth Management LLC287$2280.00%00.0%Unchanged
Carmichael Hill & Associates, Inc.525$4170.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec785$6230.00%00.0%Unchanged
Sandy Spring Bank1,050$8330.00%00.0%Unchanged
Cutler Group LP1,400$1.00K0.00%−111−7.3%Reduced
Qube Research & Technologies Ltd2,087$1.66K0.00%−19,474−90.3%Reduced
BNP Paribas Arbitrage, SA2,162$1.71K0.00%−1,891−46.7%Reduced
Wetzel Investment Advisors, Inc.3,000$2.00K0.00%+3,000New
Lazard Asset Management LLC4,160$3.00K0.00%−193−4.4%Reduced
Lindbrook Capital, LLC4,610$3.66K0.00%00.0%Unchanged
Global Retirement Partners, LLC6,000$4.26K0.00%00.0%Unchanged
Rhumbline Advisers5,912$4.69K0.00%+330+5.9%Added
Advisor Group Holdings, Inc.6,258$4.96K0.00%−4,200−40.2%Reduced
Scientech Research LLC10,205$8.09K0.01%+10,205New
Raymond James & Associates10,218$8.10K0.00%−151−1.5%Reduced
Tower Research Capital LLC (TRC)10,664$8.46K0.00%+2,627+32.7%Added
Douglas Lane & Associates, LLC11,000$8.72K0.00%00.0%Unchanged
Goldman Sachs Group Inc15,979$12.7K0.00%−41,632−72.3%Reduced
Commonwealth Equity Services, LLC16,758$13.0K0.00%−15,117−47.4%Reduced
Captrust Financial Advisors17,254$13.7K0.00%−4,670−21.3%Reduced
Independent Financial Group, LLC18,252$14.5K0.00%00.0%Unchanged
Newman Dignan & Sheerar, Inc.23,031$18.3K0.01%+23,031New
HSBC Holdings PLC26,504$18.8K0.00%+440+1.7%Added
Hunter Associates Investment Management LLC23,000$19.0K0.00%−1,000−4.2%Reduced
UBS Group AG24,693$19.6K0.00%−3,641−12.9%Reduced
Stifel Financial Corp27,259$21.6K0.00%−2,574−8.6%Reduced
X-Square Capital, LLC27,425$22.0K0.01%+654+2.4%Added
Prosperity Wealth Management, Inc.28,620$22.7K0.01%−2,000−6.5%Reduced
Virtu Financial LLC28,406$23.0K0.00%+28,406New
Simon Quick Advisors, LLC30,000$23.8K0.00%+30,000New
Janney Montgomery Scott LLC30,000$24.0K0.00%00.0%Unchanged
DLK Investment Management, LLC30,512$24.2K0.01%+30,512New
CSS LLC30,702$24.3K0.00%−60,000−66.2%Reduced
Main Street Financial Solutions, LLC31,190$24.7K0.00%00.0%Unchanged
Wealth Enhancement Advisory Services, LLC32,239$25.6K0.00%+2,000+6.6%Added
Cubist Systematic Strategies, LLC34,607$27.4K0.00%+34,607New
XTX Topco Ltd36,977$29.3K0.01%+36,977New
Barclays PLC50,061$39.7K0.00%00.0%Unchanged
Oppenheimer & Co Inc50,103$39.7K0.00%−18,068−26.5%Reduced
Wells Fargo & Company56,177$44.5K0.00%+1,432+2.6%Added
Susquehanna International Group, LLP56,846$45.1K0.00%−110,042−65.9%Reduced
Northern Trust Corp57,423$45.5K0.00%00.0%Unchanged
HRT Financial LP59,906$47.0K0.00%+59,906New
Two Sigma Advisers, LP59,837$47.5K0.00%−4,600−7.1%Reduced
Jane Street Group, LLC97,580$77.4K0.00%+97,580New
Marquette Asset Management, LLC98,589$78.2K0.01%−760−0.8%Reduced
Geode Capital Management, LLC117,909$93.5K0.00%00.0%Unchanged
Harbor Capital Advisors, Inc.147,732$117.2K0.02%+13,317+9.9%Added
BlackRock Inc.179,581$142.4K0.00%−1,086,543−85.8%Reduced
State Street Corp305,336$242.1K0.00%+6,235+2.1%Added
Key Client Fiduciary Advisors, LLC336,620$266.9K0.16%+20,295+6.4%Added
DAFNA Capital Management LLC351,064$278.4K0.07%00.0%Unchanged
Rathbone Brothers plc432,818$343.2K0.00%00.0%Unchanged
Millennium Management LLC441,032$349.7K0.00%+140,971+47.0%Added
Acuitas Investments, LLC479,789$380.5K0.20%+250.0%Added
Gsa Capital Partners LLP508,808$403.0K0.03%+508,808New
Redmile Group, LLC715,607$567.5K0.02%00.0%Unchanged
JPMorgan Chase & Co928,224$736.1K0.00%−103,193−10.0%Reduced
Renaissance Technologies LLC1,370,239$1.09M0.00%+342,379+33.3%Added
Syncona Portfolio Ltd1,377,294$1.09M0.69%00.0%Unchanged
FMR LLC1,733,141$1.37M0.00%00.0%Unchanged
Morgan Stanley1,956,658$1.55M0.00%−94,688−4.6%Reduced
Rock Springs Capital Management LP2,425,468$1.92M0.05%−362,377−13.0%Reduced
Citadel Advisors LLC3,399,514$2.70M0.00%−150,045−4.2%Reduced
Tang Capital Management LLC4,387,238$3.48M0.32%−779,716−15.1%Reduced
Bank of America Corp4,697,954$3.73M0.00%+8290.0%Added
MPM Oncology Impact Management LP5,095,912$4.04M0.95%00.0%Unchanged
MPM Asset Management LLC5,555,461$4.41M2.16%−731,640−11.6%Reduced
PFM Health Sciences, LP10,423,135$8.27M0.50%00.0%Unchanged
Baker Bros. Advisors LP10,969,282$8.70M0.10%00.0%Unchanged
Long Focus Capital Management, LLC12,086,915$9.58M1.24%+1,123,757+10.3%Added
Baillie Gifford & Co15,912,140$12.6M0.01%−1,235,269−7.2%Reduced
NEA Management Company, LLC17,079,778$13.5M0.90%00.0%Unchanged
Matrix Capital Management Company, LP38,974,185$30.9M0.32%00.0%Unchanged
Artal Group S.A.0$00.00%−1,133,775−100.0%Sold out
Citigroup Inc0$00.00%−582,275−100.0%Sold out
Endurant Capital Management LP0$00.00%−311,944−100.0%Sold out
Simplify Asset Management Inc.0$00.00%−150,000−100.0%Sold out
Black Maple Capital Management LP0$00.00%−69,839−100.0%Sold out
Two Sigma Investments, LP0$00.00%−60,074−100.0%Sold out
Invesco Ltd.0$00.00%−45,906−100.0%Sold out
ProShare Advisors LLC0$00.00%−13,466−100.0%Sold out
Courier Capital LLC0$00.00%−12,000−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−10,486−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−5,285−100.0%Sold out
US Bancorp0$00.00%−1,058−100.0%Sold out
Beaird Harris Wealth Management, LLC0$00.00%−92−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−469−100.0%Sold out